ALT
Altimmune Inc
3.30$
+0.3%
vs. previous close
Closing price · As of: Sep 18, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4.4% | -50.8% | -99.2% | +24,792.6% | -43.8% | +41.1% | -46.1% | -101.5% | – | -95.3% | +105.0% | |
| – | +18.7% | +42.6% | +154.9% | +0.3% | -7.6% | +96.4% | +120.4% | -99.3% | -4.6% | -50.1% | -52.9% | |
| – | -5.9% | -135.7% | – | – | – | -536.5% | – | -101.5% | – | -95.3% | +105.0% | |
| – | -44.9% | -5.8% | +280.6% | +0.3% | -3.8% | +180.2% | +49.8% | -5.4% | -6.7% | +25.0% | -19.2% | |
| – | -43.0% | +85.1% | -26.6% | +15.5% | -13.0% | +55.4% | +16.7% | +11.2% | +5.9% | +15.6% | +34.0% | |
| – | -43.6% | +43.5% | -2.0% | +74.6% | -3.4% | +8.1% | +243.8% | -13.5% | +9.9% | +7.1% | -8.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -74.1% | -29.5% | +321.2% | +83.2% | -99.2% | +319.8% | -46.9% | +60.0% | +337.5% | -74.3% | +18,077.8% | |
| – | – | – | -125.4% | – | – | – | – | – | – | – | – | |
| – | +0.0% | +17,989.2% | -150.5% | – | – | – | -117.0% | – | – | – | – | |
| – | – | – | -123.9% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.